Since 1989, the Lynn Health Science Institute (LHSI) has been conducting comprehensive medical research. Bringing new drugs to market through its clinical trials program, LHSI has extensive experience in a number of areas, including chronic digestive diseases; cardiovascular diseases and hypertension; disorders such as asthma, lung infections, and cystic fibrosis; women’s health; urology; rheumatoid and osteoarthritis; and sleep disorders.

By Matt Gurin

Congratulations! You’ve been promoted. You’re a global leader in the new R&D organization. This is exciting since you’ve been sweating the outcome of the long-impending transformation for over a year. The good news is that you will lead a global team spanning three continents. The bad news is that your drug development function will be spread across four global centers of excellence, and some of your colleagues will lose their jobs or be transferred.

Eurofins MWG Operon has opened a new DNA sequencing facility in the San Francisco area.